Recommendations for Determining Risk of Human Immunodeficiency Virus (HIV) Infection for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Draft Guidance for Industry

1 organizations filed 1 public comment on Recommendations for Determining Risk of Human Immunodeficiency Virus (HIV) Infection for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Draft Guidance for Industry, at the Food and Drug Administration. The comment window closed 537d ago.

Commenters (1)

• American Medical Associationtrade assoc.

  1 filing · confidence 97%